热毒宁联合利巴韦林治疗手足口病疗效分析  

Analysis of Reduning and Ribavirin to Treat 584 Cases HFMD efficacy

作　　者：龙小萍[1] 

机构地区：[1]衡阳市妇幼保健院,湖南衡阳421001

出　　处：《中外医疗》2012年第35期19-20,共2页China & Foreign Medical Treatment

摘　　要：目的分析热毒宁联合利巴韦林治疗手足口病的疗效。方法选取2011年10月—2012年6月该院收治的1168例手足口病患者,随机分为观察组(584例)和对照组(584例),观察组应用热毒宁联合利巴韦林治疗,对照组仅应用利巴韦林治疗,比较治疗后效果。结果观察组在临床症状及体征方面明显优于对照组,差异有统计学意义(P<0.05)。结论热毒宁联合利巴韦林治疗手足口病的疗效好,值得临床推广使用。Objective To analyze the efficacy of reduning and ribavirin to treat 584 cases of HFMD. Methods Selected in October 2011-June,2012 1168 cases of HFMD,randomly divided into observation group（584 cases）and control group（584 cases）,the observation group used reduning and ribavirin,and control group only used ribavirin,compared the treatment results. Results The observation group’s clinical symptoms and signs were significantly better than control group,had a significant differences（P0.05）. Conclusion Reduning and ribavirin had a good efficacy in treating 584 cases of HFMD,worthy for clinical using.

关 键 词：利巴韦林 手足口病 热毒宁 中药 疗效 

分 类 号：R725.1[医药卫生—儿科]